An mRNA Flu Vaccine Hits the Market

Podcast: Public Health On Call · The Johns Hopkins Bloomberg School of Public Health

Opublikowano: 2026-09-30

About this episode: For the first time ever, mRNA flu shots are available this respiratory virus season for adults age 50 and older, offering an opportunity to create vaccines better tailored to certain strains of the virus. Moderna's mFLUSIVA was approved by the FDA this summer and is available in some pharmacies. In this episode: Vaccine expert Anna Durbin explains how the vaccine works, discusses the current data on its safety and efficacy, and reflects on the quest for a universal flu vaccine. Guest: Dr. Anna Durbin is a professor of International Health and the director of the...